Wasdell acquires specialist packaging supplier
The acquisition will strengthen Wasdell’s capabilities and product offerings, including 100% recyclable and biodegradable options, in the medical device sector.
The Wasdell Group, a pharmaceutical outsourcing partner, has acquired Planned Packaging Limited & Planned Packaging Films Limited (PPF), a specialist packaging supplier to the medical device and pharmaceutical sectors.
The acquisition will strengthen and expand Wasdell’s capability to be a fully integrated supplier to its growing client base within the life science and medical device sector.
Planned Packaging brings over 40 years’ experience supplying leading global medical device manufacturers and pharmaceutical companies in the UK, Europe and the Americas. The products supplied comply with ISO 11607/Medical Device Reporting (MDR ) requirements and are manufactured in an ISO 8 cleanroom environment.
Vincent Dunne, Wasdell Group CEO commented: “The acquisition of PPF allows the Wasdell Group to vertically integrate into a key commodity area, safeguarding supplies but also expanding our capabilities and product and service offerings.”
The product range includes pre-made easy-peel pouches, high barrier foil films and semi-rigid materials for processing through thermoforming lines. There is also the ability to custom print on a wide range of materials as well as advise customers on the most suitable packaging solution.
As demand for more sustainable materials increases, Planned Packaging is leading the way by introducing new 100% recyclable and biodegradable options.
Martin Tedham, Chairman of the Wasdell Group added: “Planned Packaging is a perfect fit due to its synergies within the existing Wasdell operations, a shared customer base, operating within the same sectors as well as a growing demand for the assembly and packaging of medical devices seen within Wasdell’s outsourced packaging services.
“Customers will benefit from expanded services and competitive prices and the integrations of Planned Packaging into our current operations will be a beneficial and advantageous one for all involved. We are pleased to welcome the Planned Packaging team to the Wasdell family and look forward to working alongside them.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance